Clearmind Medicine Expends Global IP portfolio with Hong Kong Patent Filing for Novel Psychedelic Compounds; Targets Multi‑Billion‑Dollar PTSD Therapeutics Market | CMND Stock NewsStockTitan·Jul 19 at 10:55 PMCMND+0.62%
Pre-market hot trades in US stocks: Clearmind Medicine pre-market down 7.03%; Corning pre-market down 3.40%Price Alert·Jul 17 at 06:32 AMCMND+0.62%GLW-2.24%
Clearmind Medicine releases update on intranasal MEAI formulation retention studyPUBT·Jul 16 at 08:30 AMCMND+0.62%
Clearmind Medicine posts update on CMND-100 first-in-human trial webinar insightsPUBT·Jul 13 at 07:18 AMCMND+0.62%
Clearmind Shares Promising Real-World Insights from Ongoing CMND-100 First-in-Human Trial | CMND Stock NewsStockTitan·Jul 12 at 11:17 PMCMND+0.62%
Clearmind Medicine Responds to the U.S. Administration’s RFI for Addiction Treatment Innovations as Part of the Great American Recovery Initiative | CMND Stock NewsStockTitan·Jul 9 at 11:32 PMCMND+0.62%
Clearmind Reports Successful Formulation Feasibility Study Supporting Potential New Additional Route of Administration Development for MEAI | CMND Stock NewsStockTitan·Jul 6 at 10:42 PMCMND+0.62%
